인사이트
Insights From Our Experts
Articles
ISPOR 2020 PANEL: Evidence Standards for Medical Device Adoption by U.S. Hospitals
ARE EXISTING REGULATORY EVIDENCE STANDARDS ADEQUATE FOR INFORMING DECISIONS ON MEDICAL DEVICE ADOPTION BY U.S. HEALTHCARE PROVIDERS/HOSPITALS? Virtual ISPOR 2020 | MONDAY, May 18th, 2020 | 11:00 AM ET MODERATOR: Nicole Ferko, MSC, EVERSANA ISSUE: With cost containment…
Two Key Questions About Payer Strategies in 2020
In a PM360 Focus on Payer Strategies feature, Brian Davis addresses the question: Besides efforts to lower drug prices and increase transparency, what market access challenges/barriers will cause pharma companies the most stress this year? How…
PharmaVOICE Showcase on Connected Health and IoT
The Growing Potential of Connected IoT In PharmaVOICE’s Showcase on Connected Health and IoT, Ed Cox offers executive viewpoints on the challenges of integrating the Internet of Medical Things (IoMT) into pharma processes. “Breaking down siloes…
PharmaVOICE Outsourcing Showcase
The New Roaring 20s: How Outsourced Commercialization is the Revolution We Need. To effectively commercialize a product, traditional service silos stand in the way of true healthcare transformation. Do disparate service providers look at the life…
How COVID-19 Has Changed Payer Engagement Strategies
The healthcare industry is rightly focused on COVID-19 and its impact on patient care and allocation or utilization of healthcare resources. However, we cannot lose sight of our responsibility to provide appropriate therapeutic options for the…
Pricentric ONE Newsletter | April 2020
Good news, this month’s issue of the Pricentric Newsletter is now available for download. Download the Newsletter!
Clinical Pathways and Policy to Guard Against Misaligned Incentives
Posted by
Seth Gordon , Dr. Richard Stefanacci on 4월 29, 20204/29/20
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage overutilization and underutilization. Moving forward, the more diligent payers…
COVID-19 Payer Pulse Research Summary
Posted on 4월 29, 20204/29/20
The current public health pandemic is impacting healthcare stakeholders from doctors and nurses in the frontline to payers and PBMs. EVERSANA is monitoring the constant changes to access and benefit consideration tracking payer responses and key…
ACCESSEXPRESS® by EVERSANA Payer Coverage and Reimbursement Case Study
ACCESSEXPRESS allows you to have full control of the survey process getting answers to your most pressing business questions within hours. See how our client used our research platform to assess payer coverage and reimbursement for…
[Infographic] Defining the Digital Space
Posted on 4월 27, 20204/27/20
Despite the increased popularity of Digital Therapeutics and Digital Medicines, there is still ambiguity around their definitions. This infographic provides clarity and defines the Digital Healthcare Space. Digital Therapeutics (DTx) Evidence-based digital solutions making direct therapeutic…